サンプル依頼リスト カート
  • English
  • Korean
表紙：心臓発作診断薬の世界市場規模調査＆予測、検査別、エンドユーザー別、地域別分析、2023-2030年
市場調査レポート
商品コード
1355653

心臓発作診断薬の世界市場規模調査＆予測、検査別、エンドユーザー別、地域別分析、2023-2030年

Global Heart Attack Diagnostics Market Size study & Forecast, by Test, End User, and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
心臓発作診断薬の世界市場規模調査＆予測、検査別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年09月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心臓発作診断薬市場は、予測期間2023年から2030年にかけて7.9%以上の成長率で成長すると予測されています。

糖尿病や高血圧などの慢性疾患の有病率は増加しています。肥満度の高さ、不健康なライフスタイルへの変化、タバコの使用など、数多くの危険因子が動脈硬化を促進し、脂肪沈着や高コレステロール値の結果として冠動脈を収縮させる。市場成長の原動力は、冠動脈性心疾患患者の増加、肥満とタバコ喫煙の増加、医療支出の増加といった主な要因です。

世界保健機関（WHO）の報告書によると、心臓発作や脳卒中を含む心血管系疾患は、世界全体の死亡者数の5人に4人を占め、死亡原因の第1位となっています。さらに、低・中所得国で毎年発生する約1,300万人の死亡原因の85％を心臓発作と脳卒中が占めています。米国心臓協会の推計によると、2035年までにアメリカ人の45％が何らかの心臓病（多くは心臓発作）に罹患する可能性があり、これは心臓発作診断薬の重要な市場促進要因となりうる。また、インド全国で実施された包括的調査の結果によると、2020年には男性回答者の約14％がコレステロールの問題を経験しています。女性回答者では、10％近くがコレステロールの問題を報告したが、心臓の問題を報告したのはわずか3％でした。さらに、診断薬用製品の高価格化とR&Dの増加、新規開発機器の発売により、予測数年間は有利なビジネスチャンスが生まれます。しかし、メディケアの償還が低く、診断薬製品のコストが高いことが、2023～2030年の予測期間を通じて市場の成長を阻害しています。

心臓発作診断薬の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、米国における肥満率の上昇と心臓病患者の増加により、世界市場シェアをリードしています。しかし、アジア太平洋は、医療支出の増加と診断薬技術の進歩により、最も急成長している地域と予想されます。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 心臓発作診断薬の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 心臓発作診断薬の世界市場力学

  • 心臓発作診断薬市場の影響分析（2020～2030年）
    • 市場促進要因
      • 冠動脈性心疾患患者の増加
      • 肥満と喫煙の増加
      • 医療支出の増加
    • 市場の課題
      • メディケアの償還額の低さ
      • 診断薬の価格上昇
    • 市場機会
      • 診断薬コストの上昇
      • R&Dの増加、新規開発機器の発売

第4章 心臓発作診断薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 心臓発作診断薬の世界市場：検査別

  • 市場スナップショット
  • 心臓発作診断薬の世界市場：検査別、実績・ポテンシャル分析
  • 心臓発作診断薬の世界市場：検査別、推定・予測、2020～2030年
  • 心臓発作診断薬市場、サブセグメント分析
    • 心電図
    • 血液検査
    • 血管造影
    • コンピューター心臓断層撮影
    • その他の検査

第6章 心臓発作診断薬の世界市場：エンドユーザー別

  • 市場スナップショット
  • 心臓発作診断薬の世界市場：エンドユーザー別、実績・ポテンシャル分析
  • 心臓発作診断薬の世界市場：エンドユーザー別、推定・予測、2020～2030年
  • 心臓発作診断薬市場、サブセグメント分析
    • 病院
    • 外来手術センター
    • 診断薬センター
    • その他のエンドユーザー

第7章 心臓発作診断薬の世界市場、地域分析

  • 主要国
  • 主な新興国
  • 心臓発作診断薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 検査別、推定・予測、2020～2030年
      • エンドユーザー、推定・予測、2020～2030年
    • カナダ
  • 欧州心臓発作診断薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋心臓発作診断薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカ心臓発作診断薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東およびアフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Astrazenca PLC
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • GE Healthcare
    • Hitachi Corporation
    • Koninklijke Philips NV
    • Midmark Corporation
    • F Hoffmann-La Roche Ltd
    • Schiller AG
    • Siemens Healthineers
    • Toshiba Corporation
    • Welch Allyn Inc.

第9章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Heart Attack Diagnostics Market, report scope
  • TABLE 2. Global Heart Attack Diagnostics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Heart Attack Diagnostics Market estimates & forecasts by Test 2020-2030 (USD Billion)
  • TABLE 4. Global Heart Attack Diagnostics Market estimates & forecasts by End-user 2020-2030 (USD Billion)
  • TABLE 5. Global Heart Attack Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Heart Attack Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Heart Attack Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Heart Attack Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Heart Attack Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Heart Attack Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Heart Attack Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Heart Attack Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Heart Attack Diagnostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Heart Attack Diagnostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Heart Attack Diagnostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Heart Attack Diagnostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Heart Attack Diagnostics Market
  • TABLE 70. List of primary sources, used in the study of global Heart Attack Diagnostics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Heart Attack Diagnostics Market, research methodology
  • FIG 2. Global Heart Attack Diagnostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Heart Attack Diagnostics Market, key trends 2022
  • FIG 5. Global Heart Attack Diagnostics Market, growth prospects 2023-2030
  • FIG 6. Global Heart Attack Diagnostics Market, porters 5 force model
  • FIG 7. Global Heart Attack Diagnostics Market, pest analysis
  • FIG 8. Global Heart Attack Diagnostics Market, value chain analysis
  • FIG 9. Global Heart Attack Diagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Heart Attack Diagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Heart Attack Diagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Heart Attack Diagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Heart Attack Diagnostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Heart Attack Diagnostics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Heart Attack Diagnostics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Heart Attack Diagnostics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Heart Attack Diagnostics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Heart Attack Diagnostics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Heart Attack Diagnostics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Heart Attack Diagnostics Market is anticipated to grow with a growth rate of more than 7.9% over the forecast period 2023-2030. The prevalence of chronic illnesses such as diabetes and hypertension is growing. Numerous risk factors, including as a high body mass index, a change to an unhealthy lifestyle, and cigarette use, will promote atherosclerosis and constrict the coronary arteries as a result of fat deposition and high cholesterol levels. The market growth is driven by key factors such as increase in cases of coronary heart disease, rising obesity and tobacco smoking and increase in healthcare expenditure.

According to a World Health Organization report, cardiovascular disorders including heart attacks and strokes contribute to four out of every five fatalities globally and are the leading cause of mortality. Furthermore, heart attacks and strokes account for 85% of the roughly 13 million fatalities that take place each year in low- and middle-income nations. According to an American Heart Association estimate, 45% of Americans might have some form of heart illness (mostly a heart attack) by 2035, which could be a significant market driver for heart attack diagnostics. Also, according to the findings of a comprehensive survey conducted nationwide in India, approximately 14 percent of male respondents experienced cholesterol issues in 2020. Among female respondents, nearly ten percent reported cholesterol problems, whereas only three percent reported heart problems. Furthermore, higher cost of diagnostic products and increasing R & D, launches of novel developed devices create lucrative opportunities in the forecast years. However, low Medicare reimbursement and higher cost of diagnostic products stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Heart Attack Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is leading the global market share owing to increase in obesity rate in United States and rising number of heart patients in the region. However, Asia Pacific is expected to be the fastest growing region due to increase in healthcare expenditure and technological advancements in diagnosis.

Major market player included in this report are:

  • Astrazenca PLC
  • GE Healthcare
  • Hitachi Corporation
  • Koninklijke Philips NV
  • Midmark Corporation
  • F Hoffmann-La Roche Ltd
  • Schiller AG
  • Siemens Healthineers
  • Toshiba Corporation
  • Welch Allyn Inc.

Recent Developments in the Market:

  • In April 2021, Roche introduced the highly sensitive cardiac troponin T test (cTnT-hs) and the N-terminal pro-brain natriuretic peptide test (NT-proBNP) are two important cardiac biomarkers.
  • In March 2021, European Union certified CaRi-Heart Technology, which uses artificial intelligence to identify and predict the danger of a serious heart attack years before it occurs. British Heart Foundation and Caristo Diagnostics collaborated to create the CaRi-Heart Technology.

Global Heart Attack Diagnostics Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Test, End-User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test:

  • Electrocardiogram
  • Blood Tests
  • Angiogram
  • Computarized Cardiac Tomography
  • Other Test

By End-user:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Other End Users

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Heart Attack Diagnostics Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Heart Attack Diagnostics Market, by Test, 2020-2030 (USD Billion)
    • 1.2.3. Heart Attack Diagnostics Market, by End-user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Heart Attack Diagnostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Heart Attack Diagnostics Market Dynamics

  • 3.1. Heart Attack Diagnostics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in cases of coronary heart disease
      • 3.1.1.2. Rising obesity and tobacco smoking
      • 3.1.1.3. Increase in healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Low Medicare reimbursement
      • 3.1.2.2. Higher cost of diagnostic products
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Higher cost of diagnostic products
      • 3.1.3.2. Increasing R & D, launches of novel developed devices

Chapter 4. Global Heart Attack Diagnostics Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Heart Attack Diagnostics Market, by Test

  • 5.1. Market Snapshot
  • 5.2. Global Heart Attack Diagnostics Market by Test, Performance - Potential Analysis
  • 5.3. Global Heart Attack Diagnostics Market Estimates & Forecasts by Test 2020-2030 (USD Billion)
  • 5.4. Heart Attack Diagnostics Market, Sub Segment Analysis
    • 5.4.1. Electrocardiogram
    • 5.4.2. Blood Tests
    • 5.4.3. Angiogram
    • 5.4.4. Computerized Cardiac Tomography
    • 5.4.5. Other Tests

Chapter 6. Global Heart Attack Diagnostics Market, by End-user

  • 6.1. Market Snapshot
  • 6.2. Global Heart Attack Diagnostics Market by End-user, Performance - Potential Analysis
  • 6.3. Global Heart Attack Diagnostics Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
  • 6.4. Heart Attack Diagnostics Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Ambulatory Surgical Centers
    • 6.4.3. Diagnostic Centers
    • 6.4.4. Other End Users

Chapter 7. Global Heart Attack Diagnostics Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Heart Attack Diagnostics Market, Regional Market Snapshot
  • 7.4. North America Heart Attack Diagnostics Market
    • 7.4.1. U.S. Heart Attack Diagnostics Market
      • 7.4.1.1. Test breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End-user breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Heart Attack Diagnostics Market
  • 7.5. Europe Heart Attack Diagnostics Market Snapshot
    • 7.5.1. U.K. Heart Attack Diagnostics Market
    • 7.5.2. Germany Heart Attack Diagnostics Market
    • 7.5.3. France Heart Attack Diagnostics Market
    • 7.5.4. Spain Heart Attack Diagnostics Market
    • 7.5.5. Italy Heart Attack Diagnostics Market
    • 7.5.6. Rest of Europe Heart Attack Diagnostics Market
  • 7.6. Asia-Pacific Heart Attack Diagnostics Market Snapshot
    • 7.6.1. China Heart Attack Diagnostics Market
    • 7.6.2. India Heart Attack Diagnostics Market
    • 7.6.3. Japan Heart Attack Diagnostics Market
    • 7.6.4. Australia Heart Attack Diagnostics Market
    • 7.6.5. South Korea Heart Attack Diagnostics Market
    • 7.6.6. Rest of Asia Pacific Heart Attack Diagnostics Market
  • 7.7. Latin America Heart Attack Diagnostics Market Snapshot
    • 7.7.1. Brazil Heart Attack Diagnostics Market
    • 7.7.2. Mexico Heart Attack Diagnostics Market
  • 7.8. Middle East & Africa Heart Attack Diagnostics Market
    • 7.8.1. Saudi Arabia Heart Attack Diagnostics Market
    • 7.8.2. South Africa Heart Attack Diagnostics Market
    • 7.8.3. Rest of Middle East & Africa Heart Attack Diagnostics Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Astrazenca PLC
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. GE Healthcare
    • 8.3.3. Hitachi Corporation
    • 8.3.4. Koninklijke Philips NV
    • 8.3.5. Midmark Corporation
    • 8.3.6. F Hoffmann-La Roche Ltd
    • 8.3.7. Schiller AG
    • 8.3.8. Siemens Healthineers
    • 8.3.9. Toshiba Corporation
    • 8.3.10. Welch Allyn Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption